Cyclooxygenase-2 (COX-2), as a limited enzyme responsible for the synthesis of protaglandins(PGs), over expresses in a number of human malignances and seems to play an important role in the pathogenesis and prognosis. Although the mechanism involved in the development of malignances is not well understood yet, the multi-target anti-cancer effects of COX-2 inhibitor has been confirmed.